用于测定人血浆中前激肽释放酶、激肽释放酶抑制作用及类激肽释放酶活性的简单显色肽底物检测法。 - Suppr

Suppr

超能文献

Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.

作者信息

Gallimore M J, Friberger P

出版信息

Thromb Res. 1982 Feb 1;25(3):293-8.

PMID:6917564

Abstract

摘要

相似文献

Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.用于测定人血浆中前激肽释放酶、激肽释放酶抑制作用及类激肽释放酶活性的简单显色肽底物检测法。

Thromb Res. 1982 Feb 1;25(3):293-8.

Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.旁路途径 XII 因子非依赖性激活动脉紧张素转化酶形成级联反应：对遗传性血管性水肿 I 型和 II 型发病机制的影响。

J Allergy Clin Immunol. 2013 Aug;132(2):470-5. doi: 10.1016/j.jaci.2013.03.026. Epub 2013 May 11.

Chromogenic peptide substrate assays for determining components of the plasma kallikrein system.用于测定血浆激肽释放酶系统成分的生色肽底物分析。

Scand J Clin Lab Invest Suppl. 1985;178:127-32.

Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.寒冷促进活化以及因子 XII、前激肽释放酶和 C1 抑制剂。

Thromb Haemost. 1985 Apr 22;53(2):242-4.

Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical material.对正常受试者血浆样本及临床材料中Hageman因子、血浆前激肽释放酶、激肽释放酶“样”活性和激肽释放酶抑制作用的研究。

Adv Exp Med Biol. 1983;156 (Pt B):1109-17.

A novel chromogenic peptide for prekallikrein/kallikrein determination.一种用于检测前激肽释放酶/激肽释放酶的新型显色肽。

Clin Lab. 2009;55(3-4):106-13.

Chromogenic substrate assays for studying components of the plasma kallikrein system in health and disease.用于研究健康与疾病状态下血浆激肽释放酶系统成分的显色底物分析。

Adv Exp Med Biol. 1983;156:225-31.

Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study.内毒素诱导血浆接触系统激活的剂量依赖性：一项体外研究。

Circ Shock. 1988 Dec;26(4):419-30.

Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein.人血浆中前激肽释放酶的测定：激活前激肽释放酶的最佳条件。

J Lab Clin Med. 1978 Jan;91(1):83-95.

The bradykinin-forming cascade and its role in hereditary angioedema.缓激肽形成级联及其在遗传性血管性水肿中的作用。

Ann Allergy Asthma Immunol. 2010 Mar;104(3):193-204. doi: 10.1016/j.anai.2010.01.007.

引用本文的文献

Patterns of C1-Inhibitor Plasma Levels and Kinin-Kallikrein System Activation in Relation to COVID-19 Severity.与新冠病毒疾病严重程度相关的C1抑制物血浆水平及激肽-激肽释放酶系统激活模式

Life (Basel). 2024 Nov 21;14(12):1525. doi: 10.3390/life14121525.

A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment.一种新的猪模型揭示了主动脉夹闭后的缺血再灌注损伤，表现出明显的心肺、血栓炎症和生化变化，而 C1 抑制剂治疗无效。

Front Immunol. 2022 Apr 1;13:852119. doi: 10.3389/fimmu.2022.852119. eCollection 2022.

Analysis of Milk from Mothers Who Delivered Prematurely Reveals Few Changes in Proteases and Protease Inhibitors across Gestational Age at Birth and Infant Postnatal Age.对早产母亲乳汁的分析显示，出生时的孕周和婴儿出生后年龄对蛋白酶和蛋白酶抑制剂的影响很小。

J Nutr. 2017 Jun;147(6):1152-1159. doi: 10.3945/jn.116.244798. Epub 2017 Apr 19.

New Tools to Study Contact Activation.研究接触激活的新工具。

Front Med (Lausanne). 2016 Nov 22;3:58. doi: 10.3389/fmed.2016.00058. eCollection 2016.

Activation of the factor XII-driven contact system in Alzheimer's disease patient and mouse model plasma.阿尔茨海默病患者及小鼠模型血浆中凝血因子 XII 驱动的接触系统的激活。

Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4068-73. doi: 10.1073/pnas.1423764112. Epub 2015 Mar 16.

Ongoing contact activation in patients with hereditary angioedema.遗传性血管性水肿患者的持续接触激活。

PLoS One. 2013 Aug 27;8(8):e74043. doi: 10.1371/journal.pone.0074043. eCollection 2013.

An alternative view of the proposed alternative activities of hemopexin.对拟议的血红素结合蛋白替代活性的另一种观点。

Protein Sci. 2011 May;20(5):791-805. doi: 10.1002/pro.616. Epub 2011 Mar 30.

Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release.铁蛋白与人H-激肽原轻链结合并抑制激肽释放酶介导的缓激肽释放。

Biochem J. 2002 Jul 1;365(Pt 1):279-86. doi: 10.1042/BJ20011637.

Effects of high-dose intraperitoneal aprotinin treatment on complement activation and acute phase response in acute severe pancreatitis.大剂量腹腔内注射抑肽酶治疗对急性重症胰腺炎补体激活及急性期反应的影响

J Gastroenterol. 1996 Oct;31(5):702-9. doi: 10.1007/BF02347620.

Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients.危重症患者的血液凝固、纤维蛋白溶解因子及其抑制剂

Intensive Care Med. 1984;10(1):23-8. doi: 10.1007/BF00258064.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验